Protocol Ledger

NCT06360458 · Phase III · ACTIVE NOT RECRUITING

Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

Interventional Phase III clinical trial protocol NCT06360458 sponsored by Wan-Jin Chen in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-08-01 Enrollment: 928 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06360458
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)928 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06360458
Protocol FieldVerified Registry Value
NCT IdentifierNCT06360458
Consolidated Lead SponsorWan-Jin Chen
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment928 participants (ACTUAL)
Registered Start Date2024-08-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06360458
Hospital Research SiteLocationSite Profile
The First Affiliated Hospital of Xiamen UniversityXiamen, ChinaOpen Hospital Dossier ->
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityGuangzhou, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI